US And Canada

Galecto has filed to go public nine years after being founded in Sweden to commercialise research from Lund and Edinburgh universities.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.

Five-year commercialisation activity at the university is on the rise in terms of patents, inventions and licensing revenue.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.